Monitor Mondays

Who will Blink First? 340B Health at Center Stage as Controversy Continues

Adam Brenman | Maureen Testoni | Knicole Emanuel, Esq. | David Glaser, Esq. | Ronald Hirsch, MD Season 14 Episode 685

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 29:28

Maureen Testoni, the stalwart president and CEO of the renowned 340B Health Program, will join the long-running Monitor Mondays to

discuss Eli Lilly’s escalating demands for hospitals to submit in-house claims data as a condition of receiving 340B drug discounts. 

Who will blink first?

Register now to reserve your participation.

Broadcast segments will also include these instantly recognizable features:

·      Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds. 

·      The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors. 

·      Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.

·      Legislative Update: Folana Houston, legislative affairs analyst for Zelis, will report on current healthcare legislation.